Similar articles

• Rifampicin-dependent antibodies in twice-weekly treated patients.

  Algeorge G, Rudescu D, Alexandrescu D. Algeorge G, et al. Scand J Respir Dis Suppl. 1973;84:98-101. Scand J Respir Dis Suppl. 1973. PMID: 4522081 No abstract available.
• [Rifampicin treatment for pulmonary tuberculosis--effectiveness of rifampicin on tubercle bacilli in pulmonary lesions (author's transl)].

  Kameda K, Okamura S, Yamamoto S, Iwai K. Kameda K, et al. Kekkaku. 1975 Jul;50(7):185-9. Kekkaku. 1975. PMID: 810614 Japanese. No abstract available.
• [The sensitivity of Mycobacterium tuberculosis to rifampicin and its clinical effectiveness (author's transl)].

  Chen HL. Chen HL. Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi. 1980 Feb;3(2):104-5. Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi. 1980. PMID: 6774865 Chinese. No abstract available.
• [Aggravation and relapse of tuberculosis before and after the clinical application of rifampicin (author's transl)].

  Shimizu T. Shimizu T. Kekkaku. 1976 Dec;51(12):507-8. Kekkaku. 1976. PMID: 1018407 Japanese. No abstract available.
• [Tuberculosis in infancy nowadays (author's transl)].

  Spiess H. Spiess H. Monatsschr Kinderheilkd (1902). 1978 Jan;126(1):1-5. Monatsschr Kinderheilkd (1902). 1978. PMID: 342920 Review. German. No abstract available.